Results 121 to 130 of about 14,877 (300)

Platelet Inhibition in Percutaneous Coronary Interventions [PDF]

, 2018
: Mechanical disruption of atherosclerotic plaques at the time of percutaneous coronary intervention (PCI) is a potent stimulus for arterial thrombosis.
Roffi, Marco, Wyss, Christophe
core  

Intracoronary abciximab.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
Here we report the potential benefits of the use of intracoronary abciximab during percutaneous coronary intervention for an acute myocardial infarction.
S Ruiz, Bustillo, P, Stella, P A F M, Doevendans   +2 more
openaire   +1 more source

Attainment and Maintenance of Platelet Inhibition Through Standard Dosing of Abciximab in Patients Undergoing Percutaneous Coronary Intervention [PDF]

, 2000
Dean J. Kereiakes
openalex   +1 more source

Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: glycoprotein IIb/IIIa inhibitors, clopidogrel or both?

Vascular Health and Risk Management, 2006
Matthew A Silva1, Jennifer L Donovan1,3, Pritesh J Gandhi2, Gregory A Volturo31Massachusetts College of Pharmacy and Health Sciences, Department of Pharmacy Practice, Worcester, MA, USA; 2Alexion Pharmaceuticals, Inc., Cheshire, CT, USA; 3UMass Memorial ...
Matthew A Silva, Jennifer L Donovan, Pritesh J Gandhi, Gregory A Volturo   +3 more
doaj  

Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction [PDF]

, 2017
Recent clinical data show that the risk of coronary thrombosis after antiplatelet drugs withdrawal is much higher than that of surgical bleeding if they are continued.
Chassot, P.-G, Delabays, A., Spahn, D. R.   +2 more
core  

Attainment and Maintenance of Platelet Inhibition Through Standard Dosing of Abciximab in Diabetic and Nondiabetic Patients Undergoing Percutaneous Coronary Intervention

, 1999
Steven R. Steinhubl, Kandice Kottke‐Marchant, David J. Moliterno, Monique Rosenthal, Nikki K. Godfrey, Barry S. Coller, Eric J. Topol, A. Michael Lincoff   +7 more
openalex   +1 more source

Assessment of change of coronary artery flow using corrected TIMI frame count following abciximab adminstration during primary angioplasty for acute myocardial infarction [PDF]

, 2000
Hae Ok Jung, Ki Bae Seung, Jungwon Jang, Sang Hyun Lim, Ki Yuk Jang, Hyo Young Lim, Wook Sung Chung, Jong Jin Kim, Jang Sung Chae, Jae Hyung Kim, Soon Jo Hong, Kyu Bo Choi   +11 more
openalex   +1 more source

Intra-arterial thrombin injection of an ascending aortic pseudoaneurysm complicated by transient ischemic attack and rescued with systemic abciximab [PDF]

, 2001
Peter H. Lin, Ruth L. Bush, Frank Tong, Elliot L. Chaikof, Louis G. Martin, Alan B. Lumsden   +5 more
openalex   +1 more source

Los inhibidores de los receptores plaquetarios IIb/IIIa en los síndromes coronarios agudos. The IIb/IIIa platelet receptor inhibitors in the acute coronary syndromes.

Revista Cubana de Cardiología y Cirugía Cardiovascular, 2001
Los inhibidores de los receptores IIb/IIIa, un nuevo grupo de antiagregantes plaquetarios, son potentes bloqueadores del receptor que media la agregación plaquetaria y de ese modo bloquean la vía final común de la formación del trombo plaquetario.
Fidel Manuel Cáceres Lóriga, Horacio Pérez López   +1 more
doaj  

Advances in emerging therapies 2008 [PDF]

, 2009
Higgins, P., Lees, K.R.
core   +1 more source